{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:54:39Z","timestamp":1774367679462,"version":"3.50.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Early identification of individuals at elevated risk of cardiovascular disease and preventive treatment during childhood may reduce cardiovascular disease in adults with chronic inflammatory diseases. Children with atopic dermatitis (AD) may have elevated cardiovascular risk, but studies to date have not accounted for heterogeneity in disease activity and severity across childhood.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate whether active and more severe AD across childhood and adolescence are associated with cardiovascular risk.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This longitudinal cohort study used data collected from 1991 to 2017 for the Avon Longitudinal Study of Parents and Children, a population-based birth cohort in the United Kingdom. Participants included children alive at 1 year with assessment of AD and at least 1 cardiovascular disease risk factor at a minimum of 1 time point. Data were analyzed November 30, 2022, to February 20, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Repeated assessments of AD activity and severity across childhood and adolescence.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was cardiometabolic risk scores calculated at ages 15, 17, and 24 years. Secondary outcomes included body mass index, blood pressure, and lipid profiles measured up to 12 times between ages 3 and 24 years and ultrasonography measures of subclinical atherosclerosis at ages 17 and 24 years.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The subcohort included 9281 children, of whom 4669 (50.31%) were male. The analysis included 1001 participants (10.79%) 3 years of age, 908 (9.78%) 4 years, 838 (9.03%) 5 years, 6352 (68.44%) 7 years, 6205 (66.86%) 10 years, 5629 (60.65%) 11 years, 4968 (53.53%) 13 years, 3502 (37.73%) 15 years, 4738 (51.05%) 17 years, and 3626 (39.07%) 24 years of age. The prevalence of active AD varied by age and ranged from 13.10% to 21.58% at ages 3 through 18 years. Among participants with AD, 3.52% to 6.85% reported moderate or severe disease at each age. Multivariable linear regression models did not reveal associations between active AD and most cardiovascular risk factors; only 2 associations between AD and low-density lipoprotein cholesterol levels were found with\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.05, but they differed in the directionality of association at ages 3 and 10 years (mean difference, \u22120.33 [95% CI, \u22120.58 to \u22120.07] SDs for 3 years vs 0.14 [95% CI, 0.03-0.24] SDs at 10 years). There was no consistent evidence for dose-response effects by AD severity. There were also no associations between patterns of more active and severe AD across childhood with subclinical atherosclerosis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In a population-based UK cohort of children and adolescents followed up into early adulthood, AD, including more active and severe disease over time, was not associated with increases in markers of cardiovascular risk. This finding suggests that systematic screening of all children with AD is unlikely to improve identification of early cardiovascular risk.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2962","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:00:27Z","timestamp":1774364427000},"page":"e262962","source":"Crossref","is-referenced-by-count":0,"title":["Atopic Dermatitis and Markers of Early Cardiovascular Risk in Children and Adolescents"],"prefix":"10.1001","volume":"9","author":[{"given":"Morgan","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Iribarren","sequence":"additional","affiliation":[{"name":"Department of Research, Kaiser Permanente, Oakland, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin\u00e9ad M.","family":"Langan","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Abuabara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"5","key":"zoi260122r1","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies.","volume":"143","author":"Ascott","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"zoi260122r2","doi-asserted-by":"publisher","first-page":"k1786","DOI":"10.1136\/bmj.k1786","article-title":"Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study.","volume":"361","author":"Silverwood","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"zoi260122r3","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"zoi260122r4","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1016\/j.jaip.2020.07.018","article-title":"A preliminary 18F-FDG-PET\/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis.","volume":"8","author":"Ungar","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"zoi260122r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.01.009","article-title":"American Academy of Dermatology Guidelines: awareness of comorbidities associated with atopic dermatitis in adults.","author":"Davis","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"20","key":"zoi260122r6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa2109191","article-title":"Childhood cardiovascular risk factors and adult cardiovascular events.","volume":"386","author":"Jacobs","year":"2022","journal-title":"N Engl J Med"},{"key":"zoi260122r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117515","article-title":"Subclinical atherosclerosis in young adults predicting cardiovascular disease: The Cardiovascular Risk in Young Finns Study.","volume":"393","author":"Raitakari","year":"2024","journal-title":"Atherosclerosis"},{"issue":"1","key":"zoi260122r8","doi-asserted-by":"publisher","first-page":"15279","DOI":"10.1038\/s41598-020-72301-2","article-title":"Investigating causal relationships between body mass index and risk of atopic dermatitis: a Mendelian randomization analysis.","volume":"10","author":"Yew","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"zoi260122r9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaci.2020.04.050","article-title":"Assessment of a causal relationship between body mass index and atopic dermatitis.","volume":"147","author":"Budu-Aggrey","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"zoi260122r11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/bjd.14031","article-title":"Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study.","volume":"173","author":"Silverberg","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"zoi260122r12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/bjd.19885","article-title":"Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort.","volume":"185","author":"Mulick","year":"2021","journal-title":"Br J Dermatol"},{"issue":"9579","key":"zoi260122r13","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","article-title":"The metabolic syndrome in children and adolescents.","volume":"369","author":"Zimmet","year":"2007","journal-title":"Lancet"},{"key":"zoi260122r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103611","article-title":"Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood.","volume":"72","author":"Ojanen","year":"2021","journal-title":"EBioMedicine"},{"issue":"4","key":"zoi260122r15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","article-title":"Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.","volume":"31","author":"Greenland","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"zoi260122r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.09.285","article-title":"Atopic dermatitis and cardiovascular risk in pediatric patients: a systematic review and meta-analysis.","author":"Kern","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"13","key":"zoi260122r17","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","article-title":"Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association.","volume":"139","author":"de Ferranti","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"zoi260122r18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/CIRCULATIONAHA.123.066510","article-title":"The time to initiate anti-inflammatory therapy for patients with chronic coronary atherosclerosis has arrived.","volume":"148","author":"Ridker","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"zoi260122r19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260122r20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2340\/00015555-2795","article-title":"The association between low grade systemic inflammation and skin diseases: a cross-sectional survey in the northern Finland birth cohort 1966.","volume":"98","author":"Sinikumpu","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"zoi260122r21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaci.2013.01.057","article-title":"A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis.","volume":"132","author":"Esparza-Gordillo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"zoi260122r22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jamadermatol.2021.2657","article-title":"Association of atopic dermatitis and mental health outcomes across childhood: a longitudinal cohort study.","volume":"157","author":"Kern","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"zoi260122r23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study.","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"zoi260122r24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jaci.2019.05.040","article-title":"Clinical onset of atopic eczema: results from 2 nationally representative British birth cohorts followed through midlife.","volume":"144","author":"Abuabara","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"zoi260122r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.1241","article-title":"A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis.","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"zoi260122r26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/ije\/dyz063","article-title":"Data Resource Profile: The ALSPAC birth cohort as a platform to study the relationship of environment and health and social factors.","volume":"48","author":"Boyd","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"zoi260122r27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ije\/dyaa192","article-title":"Factors associated with participation over time in the Avon Longitudinal Study of Parents and Children: a study using linked education and primary care data.","volume":"50","author":"Cornish","year":"2021","journal-title":"Int J Epidemiol"},{"key":"zoi260122r10","unstructured":"Avon Longitudinal Study of Parents and Children. University of Bristol. Accessed January 2019. https:\/\/www.bristol.ac.uk\/alspac\/researchers\/our-data\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846927\/ye_2026_oi_260122_1773780398.54363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:00:29Z","timestamp":1774364429000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2962","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}